Abstract:Obesity has been recognized to be increasing globally and is designated a disease with adverse consequences requiring early detection and appropriate care. In addition to being related to metabolic syndrome disorders such as type 2 diabetes, hypertension, stroke, and premature coronary artery disease. Obesity is also etiologically linked to several cancers. The non-gastrointestinal cancers are breast, uterus, kidneys, ovaries, thyroid, meningioma, and thyroid. Gastrointestinal (GI) cancers are adenocarcinoma of the esophagus, liver, pancreas, gallbladder, and colorectal. The brighter side of the problem is that being overweight and obese and cigarette smoking are mostly preventable causes of cancers. Epidemiology and clinical studies have revealed that obesity is heterogeneous in clinical manifestations. In clinical practice, BMI is calculated by dividing a person's weight in kilograms by the square of the person's height in square meters (kg/m2). A BMI above 30 kg/m2 (defining obesity in many guidelines) is considered obesity. However, obesity is heterogeneous. There are subdivisions for obesity, and not all obesities are equally pathogenic. Adipose tissue, in particular, visceral adipose tissue (VAT), is endocrine and abdominal obesity (a surrogate for VAT) is evaluated by waist-hip measurements or just waist measures. Visceral Obesity, through several hormonal mechanisms, induces a low-grade chronic inflammatory state, insulin resistance, components of metabolic syndrome, and cancers. Metabolically obese, normal-weight (MONW) individuals in several Asian countries may have BMI below normal levels to diagnose obesity but suffer from many obesity-related complications. Conversely, some people have high BMI but are generally healthy with no features of metabolic syndrome. Many clinicians advise weight loss by dieting and exercise to metabolically healthy obese with large body habitus than to individuals with metabolic obesity but normal BMI. The GI cancers (esophagus, pancreas, gallbladder, liver, and colorectal) are individually discussed, emphasizing the incidence, possible pathogenesis, and preventive measures. From 2005 to 2014, most cancers associated with overweight and Obesity increased in the United States, while cancers related to other factors decreased. The standard recommendation is to offer or refer adults with a body mass index (BMI) of 30 or more to intensive, multicomponent behavioral interventions. However, the clinicians have to go beyond. They should critically evaluate BMI with due consideration for ethnicity, body habitus, and other factors that influence the type of obesity and obesity-related risks. In 2001, the Surgeon General's ``Call to Action to Prevent and Decrease Overweight and Obesity'' identified obesity as a critical public health priority for the United States. At government levels reducing obesity requires policy changes that improve the food and physical activity for all. However, implementing some policies with the most significant potential benefit to public health is politically tricky. The primary care physician, as well as subspecialists, should identify overweight and Obesity based on all the variable factors in the diagnosis. The medical community should address the prevention of overweight and Obesity as an essential part of medical care as much as vaccination in preventing infectious diseases at all levels- from childhood, to adolescence, and adults.

Excess Weight Causes Nearly 4% of New Cancers a Year Worldwide.

Estimation of Cancer Mortality Attributable to Excess Body Weight During 2006-2015 in China.

Estimation of cancer mortality attributable to excess body weight during 2006-2015 in China

Global burden of cancer attributable to high body-mass index in 2012: a population-based study

Global patterns in excess body weight and the associated cancer burden

Cancers in France in 2015 attributable to high body mass index

Proportion of Cancer Cases Attributable to Excess Body Weight by US State, 2011-2015

Global obesity epidemic and rising incidence of early-onset cancers

Excess Body Weight and Gastrointestinal Cancer Risk

Estimation of Cancer Incidence and Mortality Attributable to Overweight, Obesity, and Physical Inactivity in China.

Obesity, obesities and gastrointestinal cancers

The increasing burden of cancer attributable to high body mass index in Brazil

The Burden of Overweight and Obesity-associated Gastrointestinal Cancers in Low and Lower-middle Income Countries: A Global Burden of Disease 2019 Analysis

Cancers attributable to overweight and obesity in Italy

Health Effects of Overweight and Obesity in 195 Countries.

Quantitative Association Between Body Mass Index and the Risk of Cancer: A Global Meta-analysis of Prospective Cohort Studies.

Burden of cancer attributable to obesity, type 2 diabetes and associated risk factors

Obesity and Cancer Risk: Recent Review and Evidence

The global burden of disease attributable to high body mass index in 204 countries and territories from 1990 to 2021 with projections to 2050: An analysis of the Global Burden of Disease Study 2021

Excess Body Weight and the Risk of Second Primary Cancers Among Cancer Survivors

Association of body mass index with survival in U.S. cancer survivors: a cross-sectional study of NHANES 1999–2018